Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deucravacitinib in breast milk of lactating women
NCT06476834Phase 4Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Jun 2024
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of deucravacitinib, sponsored by Bristol Myers Squibb. Started Jun 2024; status: completed.
02
Drugs
deucravacitinib
Beyond the preview
Go deeper on NCT06476834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06476834.